Most Recent
A judge refused Tuesday to step down from two cases brought by Bendigo and Adelaide Bank seeking to claw back loans from group members in a settled class action over Great Southern Group's managed investment schemes, saying no apprehension of bias could arise.
A judge has found two patents held by an Eli Lilly & Co. unit for erectile dysfunction drug Cialis are valid and that generic manufacturer Apotex threatened to infringe the patents.
A $3 million settlement in the shareholder class action against the directors of failed mining company Kagara has been approved, with a Federal Court judge saying the amount is fair and reasonable despite two-thirds of it going to the lawyers and funder that brought the case.
A judge has ruled in-house counsel at Glencore can't view "highly confidential" documents related to the possible sale by Cargill of its Joe White malt business.
Hancock Prospecting, owned by mining magnate Mrs Gina Rinehart, is fighting a bid by daughter Ms Bianca Rinehart to access the company's books and records, saying an upcoming High Court decision may change the fate of the case.
Correspondence to a law firm revealing a client's identity was covered by legal professional privilege because the firm's advice was contingent on the client providing his name, a court has ruled.
A judge has refused a bid by two Australian companies to shut down a long-running wrongful death case in the US brought by the families of 15 people killed in an air crash near the Lockhart River in North Queensland in May 2005.
H.J. Heinz Company has been fined $2.25 million for marketing sugary snacks to kids as healthy, a fraction of the $10 million penalty sought by the ACCC.
The Commonwealth Bank of Australia is seeking to strike out portions of a shareholder class action over allegedly lax anti-money laundering and anti-terrorism financing controls it calls a "vague penumbra" that leaves the bank in the dark about the case against it.
The Full Federal Court has shot down Reckitt Benckiser's appeal of a ruling that it misled consumers with claims that its Nurofen is a more effective pain killer than rival GlaxoSmithKline's Panadol.